Menu
Fechar
hrs4r
Quiero donar

JORDI RUBIÓ CASADEVALL

Oncología de Precisión de Girona
Firma
JORDI RUBIÓ-CASADEVALL
Posición
Investigador/a Consolidat - R3
Investigador/a Consolidado - R3
Publicacions

Publicacions

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780
0

SEOM-TTCC clinical guideline in nasopharynx cancer (2021)

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 670-680 dx.doi.org/10.1007/s12094-022-02814-x

Rubió-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miró J, Urban A, Palhua RL, Martín-Romero F, Ortiz-Duran MR, Marcos-Gragera R

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19084802
0

Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14184379
0

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer

ORAL ONCOLOGY, 2022, 134, 106087-106087 dx.doi.org/10.1016/j.oraloncology.2022.106087

Rubió-Casadevall J, Galceran J, Ameijide A, Puigdemont M, Llauradó L, Marruecos J, Izquierdo A, Carulla M, Borràs JL, Marcos-Gragera R, Gumà J

Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 788-798 dx.doi.org/10.1007/s12094-020-02470-z

Martínez-Trufero J, Lozano Borbalas A, Pajares Bernad I, Taberna Sanz M, Ortega Izquierdo E, Cirauqui Cirauqui B, Rubió-Casadevall J, Plana Serrahima M, Ponce Ortega JM, Planas Toledano I, Caballero J, Marruecos Querol J, Iglesias Docampo L, Lambea Sorrosal J, Adansa JC, Mesía Nin R, Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 1666-1677 dx.doi.org/10.1007/s12094-021-02567-z

Sanvisens A, Puigdemont M, Rubió-Casadevall J, Vidal-Vila A, López-Bonet E, Martín-Romero F, Marcos-Gragera R

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 dx.doi.org/10.3390/ijerph182413269

Rubió-Casadevall J, Carbó-Bagué A, Puigdemont M, Osca-Gelis G, Oliveras G, Vilar-Coromina N, Ferrer-Fabrega B, Urban A, Llobet-Roma M, Martín-Romero F, Perez-Bueno F, Marcos-Gragera R

Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor

EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31, 616-622 dx.doi.org/10.1684/ejd.2021.4136

Fort-Culillas R, Barahona San Millán R, Garcia-Fructuoso I, Quera González A, Grau Martín A, Puigdemont Guinart M, Rubió-Casadevall J, Recasens Sala M, Porta Balanyà R

Doege-Potter syndrome in a facial solitary fibrous tumor: Diagnose and clinical management discussion

Clinical Case Reports, 2021, 9 dx.doi.org/10.1002/ccr3.4291

Formulari de contacte

Conoce el IDIBGI!

 menu